Lupin Launches generic formulation to treat ovarian cancer in United States
Pharma major Lupin Limited on Friday announced the launch of Doxorubicin Hydrochloride Liposome Injection 20 mg/10 mL (2 mg/mL) and 50 mg/25 mL (2 mg/mL) Single-Dose Vials in the United States. This comes following Lupin’s alliance partner, …